Volume 4, Issue 2, April 2019, Page: 25-28
Tumors Registry in Low Income Countries’ Hospital: A Retrospective Study of 350 Cases in the Democratic Republic of Congo from 2007 to 2017
Mwenze Didier, Pathology Department, University of Lubumbashi, Lubumbashi, Democratic Republic of Congo
Kyabu Véronique, Pathology Department, University of Lubumbashi, Lubumbashi, Democratic Republic of Congo
Mulenga Phillipe, Public Health Department, University of Lubumbashi, Lubumbashi, Democratic Republic of Congo
Mukalay Abdon, Public Health Department, University of Lubumbashi, Lubumbashi, Democratic Republic of Congo
Ilunga Julien, Pathology Department, University of Lubumbashi, Lubumbashi, Democratic Republic of Congo
Received: Apr. 2, 2019;       Accepted: May 21, 2019;       Published: Jun. 11, 2019
DOI: 10.11648/j.ijcocr.20190402.13      View  133      Downloads  19
Abstract
Tumors had been misdiagnosed and under- documented for longtime in Africa. The Democratic Republic of Congo (DRC) has not any cancer registry available up today. The National Cancer Registry is an important tool to deal with cancer management, especially for the National Cancer Plan and cancer prevention. The African Cancer Registry Network (AFCRN) is trying to help many Countries to hold their national Registries in hope to provide tumors’ data. Despite National Cancer Registry, hospital Registries can be used for preliminary researches. This is a retrospective study performed to determine epidemiological and clinical data of tumors in Lubumbashi City, the second city in DRC, especially in the mines’ hospital during the period from 2007 to 2017. The authors collected data from 350 patients aged from 2 and 94 years. The average age was 46.3 ± 17.9 years. There were 299 Females and 51 males; means 85.4 vs 14.6%. Tumors of the female reproductive system accounted for 72.9%. Diagnosis was made by echography in 59.7% of cases. Palliative care was the main treatment in 51% of cases. This study has enlightened the fact that tumors are a serious problem of health in the Democratic Republic of Congo and there are many challenges to improve cancer survival in this country.
Keywords
Tumors, Low Income Countries, Registry, Survival
To cite this article
Mwenze Didier, Kyabu Véronique, Mulenga Phillipe, Mukalay Abdon, Ilunga Julien, Tumors Registry in Low Income Countries’ Hospital: A Retrospective Study of 350 Cases in the Democratic Republic of Congo from 2007 to 2017, International Journal of Clinical Oncology and Cancer Research. Vol. 4, No. 2, 2019, pp. 25-28. doi: 10.11648/j.ijcocr.20190402.13
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Hill C, Doyon F. Fréquence des cancers en France. Bull Cancer (Paris). 2003; 90(3): 207–213.
[2]
Thijs A. Considérations sur les tumeurs malignes des indigénes du Congo belge et du Ruanda-Urundi. A propos de 2,536 cas. Ann Soc Belg Med Trop. 1957; 37: 483–514.
[3]
Goumbri OM, Domagni OE, Sanou AM, Konsegre V, Soudre RB. Aspects épidémiologiques et histopathologiques des cancers au Burkina Faso. J Afr CancerAfrican J Cancer. 2009; 1(4): 207.
[4]
Malanda JN, Mbon JBN, Bambara AT, Ibara G, Minga B, Epala BN, et al. Douze années de fonctionnement du registre des cancers de Brazzaville. Bull Cancer (Paris). 2013; 100(2): 135–139.
[5]
Mwenze Didier, Mujanay Bernard, Mukalay Abdon, Ilunga Julien. Cervical smears: morphological and epidemiological study for intra-epithelial neoplasia in Lubumbashi. International Journal of Clinical Oncology and Cancer Research 2018; 3(4): 55-58
[6]
Nday G, Kabamba M, Mukalay A, Tshilombo F, Odimba E, Lebwaz B, Kalenga P, Ilunga J. Breast Cancer: Clinical and Pathological Study at Lubumbashi and Kinshasa University Hospitals in the Democratic Republic of Congo from 2014 to 2015; International Journal of Clinical Oncology and Cancer Research 2017; 2(6): 141-148
[7]
Human Development Index 2007, the United Nations Development Programme 1 UN Plaza, New York, New York, 10017, USA: 283
[8]
Giovannini M, Bardou VJ, Barclay R, Palazzo L, Roseau G, Helbert T, et al. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study. Endoscopy. 2001; 33(03): 231–236
[9]
Baulieux J, Adham M, Oussoultzoglou E, De la Roche E, Berthoux N, Bourdeix O, et al. La pancréatectomie pour cancer avec résection des vaisseaux rétropancréatiques est-elle justifiée? Chirurgie. 1998; 123(5): 438–444.
[10]
Mignot L, Cottu PH. Les tumeurs desmoïdes. Oncol-PARIS-. 2002; 4(3): 163–170
[11]
Rigal O, Blot E, Druesne L, Chassagne P. Épidémiologie: cancer et sujet āge. Rev Francoph Psycho-Oncol. 2006; 5(3): 141–146.
[12]
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87–108.
[13]
Hasiniatsy NRE, Rabarijaona L, Rafaramino F. Évolution des aspects épidémiologiques du cancer du col utérin dans le service oncologie d’Antananarivo, MadagascarEvolution of epidemiological aspects of uterine cervix cancer in Antananarivo oncology service, Madagascar. African J Cancer. 2011; 3(1): 3–7.
[14]
Dem A, Traoré B, Dieng MM, Diop PS, Ouajdi T, Lalami MT, et al. Les cancers gynécologiques et mammaires à l’Institut du cancer de Dakar. Cah Détudes Rech Francoph. 2008; 18(1): 25–29.
[15]
Pitche P, Tchamdja S, Nappo-Koura G, Bakonde P, Kpodzro K, Tchangai-Walla K. Les cancers cutanés en consultation dermatologique à Lomé (Togo). Médecine D’Afrique Noire. 1997; 44: 15–17.
[16]
Sano DI, Cisse R, Dao B, Lankoande J, Traore SSL, Soudre RB, et al. Le cancer du sein: problèmes diagnostiques et thérapêutiques au CHU de Ouagadougou. Médecine D’Afrique Noire. 1998; 45(5).
[17]
Harouna YD. La femme d’Afrique et son chirurgien face au cancer du sein. Médecine Afr Noire. 2001; 48(2).
[18]
Karayuba R, Armstrong O, Bigirima V, Ndarugirire F, Ngendahayo L, Marerwageta L. Le traitement chirurgical des cancers gastriques au CHU de Kamenge (Bujumbura). A propos de 53 cas. Med D’Afrique Noire. 1993; 40: 605–608.
[19]
Toure M, Nguessan E, Bambara AT, Kouassi YKK, Dia JML, Adoubi I. Facteurs liés au diagnostic tardif des cancers du sein en Afrique-sub-saharienne: cas de la Côte d’Ivoire. Gynécologie Obstétrique Fertil. 2013; 41(12): 696–700.
[20]
Takongmo S, Yomi J, Guifo ML, Tangnyin CP, Ndom P, Nkodo JM, et al. Chimiothérapie néoadjuvante et cancers du sein avancés ou inflammatoires à Yaoundé (Cameroun) Neoadjuvant chemotherapy in the treatment of advanced and inflammatory breast cancer in Yaoundé (Cameroon). J Afr CancerAfrican J Cancer. 2011; 3(3): 175–179
[21]
Ilunga Nikulu Julien, Lukamba Mbuli Robert, Chenge Gaby, Ngoy Numbi Marcel, Kanteng Gray, Mutoke Guélord, Kyabu Kabila and Mwenze Mwadi. Retinoblastoma: A Retrospective Study of 27Cases at the University Teaching Hospital of Lubumbashi-DRC. J Cancer Sci Clin Oncol: 3(2): 2016: 206.
[22]
Ilunga J, Raphael M, Hurwitz N, Leoncini L, Githang’a J, Lebwaze B, Chumba D, Anani L. Telepathology: Role in improving laboratory techniques, diagnosis and research in low resource countries. East African Journal of Pathology 2015; 2(1): 30-33.
[23]
Nday Guy, Kabamba Michel, Mukalay Abdon, Tshilombo François, Odimba Etienne, Lebwaz Bienvenu, Kalenga Prospère, Ilunga Julien. Expression of Ki-67 and Prognosis of Breast Invasive Carcinoma in Congolese Women. International Journal of Clinical Oncology and Cancer Research 2018; 3(1): 1-9
[24]
Le Registres des cancers: in Les Cancers en Afrique. June 2017. Source ALIAM Contre le Cancer: Paris, France: 23.
Browse journals by subject